A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Sensitive Method to Quantify Senescent Cancer Cells

20.7K views

⸱

DOI:

10.3791/50494

⸱

August 2nd, 2013

 , 

In This Article

Summary

Whether senescence prevents or promotes tumorigenesis remains controversial. Since chemotherapeutical drugs can induce cancer cells to senesce, studying senescence is essential for proposing new therapies. However, the standard and broadly used β-galactosidase assay presents major drawbacks. We propose here a rapid and sensitive flow cytometry-based assay to quantify senescence.

Abstract

Human cells do not indefinitely proliferate. Upon external and/or intrinsic cues, cells might die or enter a stable cell cycle arrest called senescence. Several cellular mechanisms, such as telomere shortening and abnormal expression of mitogenic oncogenes, have been shown to cause senescence. Senescence is not restricted to normal cells; cancer cells have also been reported to senesce.

Chemotherapeutical drugs have been shown to induce senescence in cancer cells. However, it remains controversial whether senescence prevents or promotes tumorigenesis. As it might eventually be patient-specific, a rapid and sensitive method to assess senescence in cancer cell will soon be required.

To this end, the standard β-galactosidase assay, the currently used method, presents major drawbacks: it is time consuming and not sensitive. We propose here a flow cytometry-based assay to study senescence on live cells. This assay offers the advantage of being rapid, sensitive, and can be coupled to the immunolabeling of various cellular markers.

Introduction

Since early sixties and its discovery by Hayflick and Moorhead, senescence still remains a cellular curiosity 1. Human cells do not indefinitely proliferate and, by senescence, Hayflick and Moorhead coined the cellular process of ageing. Senescence is a stable cell cycle arrest in which cells remain metabolically active as opposed to cellular death. To date, four cellular mechanisms have been shown to induce senescence: telomere shortening, DNA damage, chromatin perturbation, and abnormal expression of mitogenic oncogenes 2. This indicates that not only normal cells but also cancer cells are able to undergo senescence 3. As a matter of....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation of C12FDG, Bafilomycin A1, and Cell Culture

  1. Dissolve the C12FDG powder in dimethyl sulfoxide (DMSO) to a final concentration of 20 mM. Aliquot and store at -20 °C. DMSO should be used with appropriate safety conditions.
  2. Dissolve the bafilomycin A1 powder in DMSO to a final concentration of 0.1 mM. Aliquot and store at - 20 °C. Bafilomycin should be used with appropriate safety conditions.
  3. Cultivate RPMI 8226 cell line, or other cell lines adherent or not, in media containing 10% fetal bovine serum and 1% antibiotics, at 37 °C, 5% CO2. Estimate the number of cells needed for the experiment....

Access restricted. Please log in or start a trial to view this content.

Results

Multiple Myeloma, a hematological malignancy, was used to evaluate the senescence induced by a chemotherapeutical procedure. To do so a commercially available MM cell line (RPMI 8226) was treated for 2 days with doxorubicin, a chemotherapeutical drug. The cells were then subjected to bafilomycin A1 treatment and further incubated with C12FDG. Cells were analyzed by flow cytometry. Figure 1 illustrates the different steps and shows that the percentage of senescent cells can be determined within.......

Access restricted. Please log in or start a trial to view this content.

Discussion

We presented here a flow cytometry-based method to quantify cellular senescence in live cancer cells. This method is based on the use of the membrane permeable compound, the C12FDG, and can therefore be used in any cell types and after various treatments as long as the compound is taken up by the cells. Upon cellular uptake, the C12FDG is hydrolyzed by the β-galactosidase, enriched in lysosomes of senescent cells. After laser excitation, the compound emits green fluorescence, allowing fo.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest declared.

Acknowledgements

We thank the SF 4206 ICORE (Université de Caen) for the use of the cytometry facility. J.C. received post-doctoral fellowships from Conseil de Radioprotection d'EDF and Conseil Régional of Basse-Normandie. Those data were part of projects funded by the Ligue Nationale contre le Cancer - Comités de l'Orne et du Calvados.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
5-dodecanoylaminofluorescein di-β-D-galactopyranoside InvitrogenD-2893
Dimethyl sulfoxide SigmaD2650
Bafilomycin A1SigmaB1793
DoxorubicinSandoz
Trypan blueSigmaT8154
RPMI 1640 cell culture mediumLonzaBE12-702
Fetal calf serumPAA Laboratories GmBHA15 101
AntibioticsGibco5290-018
Gallios flow cytometerBeckman CoulterA94291

References

  1. Hayflick, L., Moorhead, P. S. The serial cultivation of human diploid cell strains. Experimental Cell Research. 25, 585-621 (1961).
  2. Campisi, J., d'Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nature Review Molecular Cell Biolo....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Flow Cytometry AssayC12 FDG SubstrateBeta Galactosidase ActivityDoxorubicin TreatmentFluorescence QuantificationCell Viability AnalysisImmunolabeling ControlsChemotherapeutic Drug ScreeningSenescence Detection Method